Gene: RFESD
Official Full Name: Rieske Fe-S domain containingprovided by HGNC
Gene Summary: Predicted to enable 2 iron, 2 sulfur cluster binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27409 | RFESD Knockout cell line (HeLa) | Human | RFESD | 1:3~1:6 | Negative | Online Inquiry |
KO27410 | RFESD Knockout cell line (HCT 116) | Human | RFESD | 1:2~1:4 | Negative | Online Inquiry |
KO27411 | RFESD Knockout cell line (HEK293) | Human | RFESD | 1:3~1:6 | Negative | Online Inquiry |
KO27412 | RFESD Knockout cell line (A549) | Human | RFESD | 1:3~1:4 | Negative | Online Inquiry |
RFESD Gene Knockout Cell Lines are bespoke, genetically modified cellular systems specifically designed to facilitate rigorous studies of the RFESD gene, which is implicated in various biological processes including cell proliferation, differentiation, and apoptosis. By employing CRISPR-Cas9 technology, these cell lines effectively disrupt the RFESD gene, enabling researchers to observe the resultant phenotypic changes and biological pathways influenced by this gene.
The key function of RFESD Gene Knockout Cell Lines lies in their ability to provide a controlled environment where the absence of the RFESD protein can be examined in isolation. This offers invaluable insights into the gene's role within cell biology, immune responses, and potential contributions to disease states. Through comparative analyses with wild-type cell lines, investigators can delineate functional changes, thus accelerating the discovery of therapeutic targets and biomarker identification in disease models.
The scientific importance of these cell lines cannot be overstated; they are vital tools in molecular biology, cancer research, and pharmacogenomics. Researchers can utilize these models in high-throughput screening assays, disease mechanism studies, and the evaluation of drug responses, thereby enabling novel therapeutic strategies.
Compared to conventional methods, such as RNA interference, RFESD Gene Knockout Cell Lines provide a more permanent and effective gene disruption, leading to clearer insights into the gene's function. They are also less likely to produce off-target effects, which enhances the reliability of experimental results.
For researchers and clinicians alike, the value of RFESD Gene Knockout Cell Lines is profound. They offer a unique opportunity to dissect complex cellular interactions and enhance our understanding of genetic regulation in health and disease, ultimately contributing to improved treatment approaches and patient outcomes.
Our company is dedicated to advancing biological research by providing high-quality, precisely engineered cell lines and reagents. With a strong foundation in genetic engineering and cell biology, we empower scientists to push the boundaries of discovery and innovation in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.